newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Broadens Patent Estate for Oral Sulopenem

DUBLIN and CHICAGO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (Iterum), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat